Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Exelixis
Exelixis
Exelixis Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Fri, 02/22/13 - 11:09 am
earnings
Exelixis
What's Ahead for Exelixis?
Motley Fool
Sun, 02/3/13 - 11:36 am
Exelixis
Genentech takes Exelixis drug into Phase III melanoma trial
Bizjournals.com
Thu, 01/17/13 - 10:19 am
Exelixis
Genentech
melanoma
Roche
Zelboraf
GDC-0973
JPMorgan Healthcare Conference Highlights: Exelixis
Motley Fool
Mon, 01/14/13 - 12:30 pm
Exelixis
JPMHC 2013
Cometriq
medullary thyroid cancer
3 Biotech Stocks You Can Buy in 2013
Motley Fool
Fri, 01/4/13 - 11:16 am
Gilead
Exelixis
Dendreon
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 10:44 am
Arqule
Array Biopharma
Celldex
Aveo Pharmaceutical
Curis
Exelixis
MorphoSys
Genmab
Novartis
Incyte
Seattle Genetics
YM BioSciences
Aveo Pharmaceuticals: A Hidden Gem Or A Hidden Disaster
Seeking Alpha
Mon, 12/10/12 - 12:30 pm
Aveo Pharmaceutical
tivozanib
Pfizer
ONYX Pharmaceuticals
Novartis
GSK
Eli Lilly
Exelixis
The Worst-Performing Biotechs in 2012 and 1 to Avoid in 2013
Motley Fool
Sun, 12/9/12 - 01:21 pm
Chelsea Therapeutics
Cell Therapeutics
Aeterna Zentaris
Progenics Pharmaceuticals
Aveo Pharmaceutical
Exelixis
The Road Toward Far-Reaching Therapeutics Through Illumina, Sarepta
Seeking Alpha
Tue, 12/4/12 - 01:36 pm
Sarepta
Illumina
Life Technologies
Exelixis
Exelixis' Crowning Achievement
Motley Fool
Sat, 12/1/12 - 09:26 am
Exelixis
cabozantinib
Cometriq
thyroid cancer
medullary thyroid cancer
Exelixis Wins First Approval of Cancer Drug
Minyanville
Fri, 11/30/12 - 09:37 am
medullary thyroid cancer
Exelixis
Cometriq
Exelixis Traders Brace For Upcoming FDA Decision
Seeking Alpha
Tue, 11/27/12 - 11:10 am
FDA
Exelixis
medullary thyroid cancer
cabozantinib
Exelixis's Cabozantinib Should Receive FDA Approval, But Faces Long-Term Challenges
Seeking Alpha
Mon, 11/26/12 - 10:55 am
cabozantinib
FDA
Exelixis
medullary thyroid cancer
Exelixis, Celgene, Gilead Sciences, Dynavax See Key Dates in November
Minyanville
Wed, 10/31/12 - 11:52 am
Exelixis
Celgene
Gilead
Dynavax
ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?
Seeking Alpha
Fri, 10/12/12 - 12:17 pm
Arqule
tivantinib
Exelixis
cabozantinib
non-small cell lung cancer
Exelixis: First Partnered Program Enters Phase III
Seeking Alpha
Wed, 10/3/12 - 11:20 am
Exelixis
Roche
GSK
GDC-0973
MEK inhibitor
melanoma
Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at ESMO 2012
Yahoo/BusinessWire
Sun, 09/30/12 - 10:31 am
cabozantinib
Exelixis
solid tumors
Exelixis Announces Data Presentation for GDC-0973 (XL518)
Yahoo/BusinessWire
Sat, 09/29/12 - 11:59 am
Exelixis
GDC-0973
XL518
melanoma
Exelixis Provides Update on ODAC Panel for Cabozantinib
Yahoo
Thu, 08/30/12 - 09:46 am
Exelixis
cabozantinib
medullary thyroid cancer
Upcoming Catalysts For Exelixis And Immunogen
Seeking Alpha
Mon, 08/27/12 - 10:32 am
Exelixis
Immunogen
prostate cancer
breast cancer
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »